European Investor LSP Raises $600M For Life Sciences Fund
LSP says its new fund for medical device and drug development companies will be the biggest fund dedicated to life sciences companies in Europe.
You may also be interested in...
Thermo Fisher expects the deal to improve its portfolio of specialty diagnostics for clinical labs while its genetic analysis technologies, biosciences reagents and consumable products will complement Qiagens’ sample preparation and assay technologies.
Start-ups focused on women's health are pioneering a revolution in the tech market. Medtech Insight spotlights four innovative femtech companies trying to shape the future of women’s health.
One year on from its IPO on Euronext Brussels, abdominal implant maker Sequana Medical has secured €19m ($21m) in an equity placement. The company said it had been backed by new and existing investors.